Published by Josh White on 21st June 2023
(Sharecast News) - Life sciences company Avacta announced the successful completion of the fifth dose escalation cohort in the phase 1 clinical trial for AVA6000 on Wednesday.
URL: http://www.digitallook.com/dl/news/story/33588174/...